Project Details
Description
Multi-center (2; possibly 3 sites) to determine whether the oral administration of one or more of 3 different doses of bovine type II collagen (CII) given to patients w/2 years or less of rheumatoid arthritis (RA) and who are not taking non-steroidal anti-inflammatory drugs (NSAIDs), prednisone, or disease modifying anti rheumatic drugs (DMARDs) is superior in efficacy to the NSAID Celebrex (celecoxib).
Status | Finished |
---|---|
Effective start/end date | 10/1/99 → 9/30/01 |
Funding
- National Center for Research Resources
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.